Keywords: dutch, unit, centocor, expanding, netherlands-based, centoco, biotechnology
Dutch Unit Of Centocor Expanding
Article | 05 May 1997
Netherlands-based Centoco, a unit of US biotechnology company Centocor,is to invest 60 million guilders ($31.4 million) in the extension of production ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
